Tofacitinib versus belimumab in maintenance therapy of systemic lupus erythematosus: A real-world CSTAR cohort study.

Qin Q, Yuan Q, Xue J, Wu L, Yang J, Duan X, Luo H, Zeng J, Li H, Wei W, Ma L, Huang C, Bai W, Zhang S, Zhao J, Wang Q, Tian X, Zeng X, Zhang Y, Li M

Open source

DOI: 10.1097/cm9.0000000000004252
Published: 2026 Sep 21
Container: Chinese medical journal
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/cm9.0000000000004252,
  title = {Tofacitinib versus belimumab in maintenance therapy of systemic lupus erythematosus: A real-world CSTAR cohort study.},
  author = {Qin Q and Yuan Q and Xue J and Wu L and Yang J and Duan X and Luo H and Zeng J and Li H and Wei W and Ma L and Huang C and Bai W and Zhang S and Zhao J and Wang Q and Tian X and Zeng X and Zhang Y and Li M},
  year = {2026},
  journal = {Chinese medical journal},
  doi = {10.1097/cm9.0000000000004252},
  url = {https://doi.org/10.1097/cm9.0000000000004252}
}

RIS

TY  - JOUR
TI  - Tofacitinib versus belimumab in maintenance therapy of systemic lupus erythematosus: A real-world CSTAR cohort study.
AU  - Qin Q
AU  - Yuan Q
AU  - Xue J
AU  - Wu L
AU  - Yang J
AU  - Duan X
AU  - Luo H
AU  - Zeng J
AU  - Li H
AU  - Wei W
AU  - Ma L
AU  - Huang C
AU  - Bai W
AU  - Zhang S
AU  - Zhao J
AU  - Wang Q
AU  - Tian X
AU  - Zeng X
AU  - Zhang Y
AU  - Li M
PY  - 2026
JO  - Chinese medical journal
DO  - 10.1097/cm9.0000000000004252
UR  - https://doi.org/10.1097/cm9.0000000000004252
ER  -

APA

Q, Q., Q, Y., J, X., L, W., J, Y., X, D., H, L., J, Z., H, L., W, W., L, M., C, H., W, B., S, Z., J, Z., Q, W., X, T., X, Z., Y, Z., & M, L. (2026). Tofacitinib versus belimumab in maintenance therapy of systemic lupus erythematosus: A real-world CSTAR cohort study.. Chinese medical journal. https://doi.org/10.1097/cm9.0000000000004252

Source records

pubmed · retrieved 2026-09-26T16:00:52.276Z